Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

bFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors

Abstract

The development of red blood cells from hematopoietic progenitors requires the interplay of specific extracellular factors and transcriptional regulators. Here we have identified an erythroid progenitor that is critically dependent on bFGF and requires expression of AMV v-Myb for sustained proliferation in vitro, indicating that bFGF and Myb proteins cooperate in these cells. In the presence of bFGF such v-Myb cells are completely blocked in their ability to differentiate and exhibit an exceptionally high proliferative potential and long lifespan in vitro. Interestingly, in the absence of bFGF cells effectively differentiate into mature erythrocytes, irrespective of constitutive and elevated levels of v-Myb. We also demonstrate that these cells express high levels of FGF receptor type 1 (FGFR1) and that phospholipase Cγ (PLCγ) is one of the important molecules in FGF receptor signaling. Our studies suggest that bFGF, in cooperation with Myb proteins, represents an important factor for determining erythroid lineage choice. These findings unravel a so far unidentified link between extracellular signaling and Myb in hematopoietic cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Akashi K, Traver D, Miyamoto T, Weissman IL . 2000 Nature 404: 193–197

  • Allouche M . 1995 Leukemia 9: 937–942

  • Bartunek P, Karafiat V, Dvorakova M, Zahorova V, Mandikova S, Zenke M, Dvorak M . 1997 Oncogene 15: 2939–2949

  • Bartunek P, Pichlikova L, Stengl G, Boehmelt G, Martin FH, Beug H, Dvorak M, Zenke M . 1996 Cytokine 8: 14–20

  • Bartunek P, Zenke M . 1998 Mol. Endocrinol. 12: 1269–1279

  • Beug H, Metz T, Mullner EW, Hayman MJ . 1996 Curr. Top. Microbiol. Immunol. 211: 29–39

  • Beug H, Steinlein P, Bartunek P, Hayman MJ . 1995 Methods Enzymol. 254: 41–76

  • Briegel K, Bartunek P, Stengl G, Lim KC, Beug H, Engel JD, Zenke M . 1996 Development 122: 3839–3850

  • Broudy VC . 1997 Blood 90: 1345–1364

  • Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL . 1993 Blood 81: 631–638

  • Cross MA, Enver T . 1997 Curr. Opin. Genet. Dev. 7: 609–613

  • Cuddihy AE, Brents LA, Aziz N, Bender TP, Kuehl WM . 1993 Mol. Cell. Biol. 13: 3505–3513

  • Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ . 1995 Development 121: 1845–1854

  • Disela C, Glineur C, Bugge T, Sap J, Stengl G, Dodgson J, Stunnenberg H, Beug H, Zenke M . 1991 Genes Dev. 5: 2033–2047

  • Dolznig H, Bartunek P, Nasmyth K, Mullner EW, Beug H . 1995 Cell. Growth Differ. 6: 1341–1352

  • Faloon P, Arentson E, Kazarov A, Deng CX, Porcher C, Orkin S, Choi K . 2000 Development 127: 1931–1941

  • Gandrillon O, Schmidt U, Beug H, Samarut J . 1999 EMBO J. 18: 2764–2781

  • Ganter B, Lipsick JS . 1999 Adv. Cancer Res. 76: 21–60

  • Garrido C, Grasser F, Lipsick JS, Stehelin D, Saule S . 1992 J. Virol. 66: 6773–6776

  • Gordon-Thomson C, Fabian BC . 1994 Development 120: 3571–3579

  • Graf T . 1992 Curr. Opin. Genet. Dev. 2: 249–255

  • Graf T . 1998 Curr. Biol. 8: 353–355

  • Huber TL, Zhou Y, Mead PE, Zon LI . 1998 Blood 92: 4128–4137

  • Karafiat V, Dvorakova M, Pajer P, Kralova J, Horejsi Z, Cermak V, Bartunek P, Zenke M, Dvorak M . 2001 Blood 98: 3668–3676

  • Klint P, Claesson-Welsh L . 1999 Front. Biosci. 4: 165–177

  • Koritschoner NP, Bartunek P, Knespel S, Blendinger G, Zenke M . 1999 Oncogene 18: 5904–5914

  • Kornfeld S, Beug H, Doederlein G, Graf T . 1983 Exp. Cell. Res. 143: 383–394

  • Krantz SB . 1991 Blood 77: 419–434

  • Krystal G, Lam V, Dragowska W, Takahashi C, Appel J, Gontier A, Jenkins A, Lam H, Quon L, Lansdorp P . 1994 J. Exp. Med. 180: 851–860

  • Lipsick JS, Ibanez CE, Baluda MA . 1986 J. Virol. 59: 267–275

  • Lyon JJ, Watson RJ . 1995 Differentiation 59: 171–178

  • Mead PE, Zon LI . 1998 Curr. Opin. Hematol. 5: 156–160

  • Mink S, Kerber U, Klempnauer KH . 1996 Mol. Cell. Biol. 16: 1316–1325

  • Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ, Potter SS . 1991 Cell 65: 677–689

  • Ness SA . 1996 Biochim. Biophys. Acta 1288: 123–139

  • Ness SA, Engel JD . 1994 Curr. Opin. Genet. Dev. 4: 718–724

  • Ness SA, Marknell A, Graf T . 1989 Cell 59: 1115–1125

  • Orkin SH . 1996 Curr. Opin. Genet. Dev. 6: 597–602

  • Orkin SH . 2000 Nat. Med. 6: 1212–1123

  • Pasquale EB . 1990 Proc. Natl. Acad. Sci. USA 87: 5812–5816

  • Pecenka V, Dvorak M, Travnicek M . 1988 Folia Biol. 34: 129–146

  • Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M . 2000 Mol. Cell 6: 743–750

  • Schmidt JA, Marshall J, Hayman MJ, Beug H . 1986 Exp. Cell Res. 164: 71–78

  • Sieweke MH, Graf T . 1998 Curr. Opin. Genet. Dev. 8: 545–551

  • Steinlein P, Wessely O, Meyer S, Deiner EM, Hayman MJ, Beug H . 1995 Curr. Biol. 5: 191–204

  • Szebenyi G, Fallon JF . 1999 Int. Rev. Cytol. 185: 45–106

  • Turque N, Plaza S, Klempnauer KH, Saule S . 1997 J. Virol. 71: 9778–9781

  • Weston K . 1998 Curr. Opin. Genet. Dev. 8: 76–81

  • Wu H, Liu X, Jaenisch R, Lodish HF . 1995 Cell 83: 59–67

  • Yuen D, Mittal L, Deng CX, Choi K . 1998 Blood 91: 3202–3209

  • Zenke M, Munoz A, Sap J, Vennstrom B, Beug H . 1990 Cell 61: 1035–1049

Download references

Acknowledgements

We thank C Corbel, DL Ewert, J Kaufmann and O Vainio for monoclonal antibodies, J Lipsick and E Pasquale for recombinant plasmid DNA, H Beug and G Christofori for critical reading of the manuscript and I Gallagher for typing the manuscript. This work was funded by grants from the Grant Agency of the Czech Republic 301/98/K042 and 204/00/0554, by the grant A5052805 from the Grant Agency of the Academy of Sciences of the Czech Republic to M Dvořák, a grant of the Fonds der Chemischen Industrie to M Zenke, and by the grant from Howard Hughes Medical Institute (HHMI, No. 75195-540401) to M Dvořák and M Zenke. M Dvořák was an International Research Scholar of the Howard Hughes Medical Institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Zenke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartůněk, P., Pajer, P., Karafiát, V. et al. bFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors. Oncogene 21, 400–410 (2002). https://doi.org/10.1038/sj.onc.1205103

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205103

Keywords

Search

Quick links